The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later ...

A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the progression of Parkinson’s disease, pointing to another potential use for the fast-growing drug ...

BIRMINGHAM, Ala. (WBRC) - Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become popular when used as a weight loss drug. But, ...

Ozempic is synonymous with weight loss for many people, even as they can turn to drugs with other brand names that have been tailored to treat obesity. The blockbuster Type 2 diabetes medication ...

After hours: February 18 at 5:44:48 PM EST Loading Chart for GLP ...

Dan Draper has Radio 1's Early Breakfast.